Also trades as: NVO (NYSE) · $vol 469M · NOVO-B.CO (CPH) · $vol 179M · NOV.DE (XETRA) · $vol 8M · NOVC.DE (XETRA) · $vol 5M · NOVO.TO (TSX) · $vol 0M
NONOF OTC
Novo Nordisk A/S
1W: -4.3%
1M: -21.0%
3M: -24.3%
YTD: -29.8%
1Y: -35.0%
3Y: -57.8%
5Y: -22.6%
$37.01
-0.37 (-0.99%)
Weekly Expected Move ±4.1%
$34
$36
$37
$39
$40
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Balance Sheet Trends
Total Assets
$541.7B
+16.3% ▲
5Y CAGR: +30.2%
Total Liabilities
$348.1B
+8.0% ▲
5Y CAGR: +33.7%
Shareholders Equity
$193.6B
+34.9% ▲
5Y CAGR: +25.0%
Cash & Investments
$26.9B
+2.3% ▲
5Y CAGR: +16.1%
Total Debt
$137.9B
+34.1% ▲
5Y CAGR: +67.8%
Net Debt
$111.5B
+27.9% ▲
Assets vs Liabilities & Equity
Year-over-Year Growth
View Full Balance Sheet
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| — Assets — | |||||
| Cash | $10.7B | $12.7B | $14.4B | $15.7B | $26.4B |
| Short-Term Investments | $6.8B | $10.9B | $15.8B | $10.7B | $497M |
| Cash & ST Investments | $17.5B | $23.6B | $30.2B | $26.3B | $26.9B |
| Net Receivables | $46.8B | $57.5B | $75.3B | $87.4B | $75.5B |
| Inventory | $19.6B | $24.4B | $31.8B | $40.8B | $49.5B |
| Other Current Assets | $7.8B | $2.7B | $2.3B | $6.3B | $20.1B |
| Total Current Assets | $85.6B | $108.2B | $139.6B | $160.9B | $172.1B |
| Property, Plant & Equip. | $55.4B | $66.7B | $91.0B | $162.5B | $207.9B |
| Goodwill & Intangibles | $43.2B | $50.9B | $60.4B | $111.1B | $129.8B |
| Long-Term Investments | $1.4B | $1.3B | $1.7B | $2.7B | $2.5B |
| Other Non-Current Assets | $267M | $206M | $1.4B | $4.0B | $5.9B |
| Total Non-Current Assets | $108.9B | $133.1B | $174.8B | $304.9B | $369.6B |
| Total Assets | $194.5B | $241.3B | $314.5B | $465.8B | $541.7B |
| — Liabilities — | |||||
| Accounts Payable | $8.9B | $15.6B | $25.6B | $28.8B | $19.7B |
| Short-Term Debt | $12.9B | $480M | $5.3B | $11.8B | $10.7B |
| Deferred Revenue | $55.2B | $0 | $0 | $0 | $0 |
| Other Current Liabilities | $21.8B | $103.9B | $38.1B | $165.9B | $175.0B |
| Total Current Liabilities | $99.5B | $120.9B | $169.7B | $217.5B | $215.2B |
| Long-Term Debt | $9.7B | $20.8B | $16.0B | $84.2B | $118.7B |
| Other Non-Current Liab. | $360M | $5.5B | $7.6B | $9.7B | $405M |
| Total Non-Current Liabilities | $24.2B | $36.8B | $38.3B | $104.8B | $132.9B |
| Total Liabilities | $123.8B | $157.8B | $207.9B | $322.3B | $348.1B |
| — Equity — | |||||
| Common Stock | $462M | $456M | $451M | $446M | $445M |
| Retained Earnings | $72.0B | $80.6B | $104.8B | $144.4B | $194.9B |
| Accumulated OCI | -$1.7B | $2.4B | $1.3B | -$1.4B | -$1.7B |
| Total Stockholders Equity | $70.7B | $83.5B | $106.6B | $143.5B | $193.6B |
| Total Liabilities & Equity | $194.5B | $241.3B | $314.5B | $465.8B | $541.7B |
| — Key Metrics — | |||||
| Total Debt | $26.6B | $25.8B | $27.0B | $102.8B | $137.9B |
| Net Debt | $15.9B | $13.1B | $12.6B | $87.1B | $111.5B |
| Total Investments | $8.2B | $12.3B | $17.5B | $13.3B | $3.0B |